In summary, the characterization of ischemia-induced metabolic reprogramming in HCC cellsenabled the development a DNP-13C-MRS imaging strategy to detect latent, treatment-refractory latent cellular domains following TA(C)E. This approach emphasizes the power of integrating uniqueaspects of cancer biology with functional imaging technologies to address deficiencies inconventional imaging paradigms.